FinancialContent

CohBar, Inc. - Common Stock (NQ:CWBR)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about CohBar, Inc. - Common Stock

News headline image
CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)
From CohBar, Inc.
Via Business Wire
News headline image
COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
CohBar Reports Second Quarter 2023 Financial Results
From CohBar, Inc.
Via GlobeNewswire
CohBar Inc. (NASDAQ: CWBR) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CIRCOR International, Inc. (NYSE - CIR), CohBar, Inc. (Nasdaq – CWBR), Greenhill & Co., Inc. (NYSE – GHL), PDC Energy, Inc. (Nasdaq – PDCE)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)
From CohBar, Inc.
Via GlobeNewswire
News headline image
COHBAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of CohBar, Inc. - CWBR
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Embark Technology, Inc. (Nasdaq – EMBK), CohBar, Inc. (Nasdaq – CWBR), Greenhill & Co., Inc. (NYSE – GHL), PDC Energy, Inc. (Nasdaq – PDCE)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
From CohBar, Inc.; Morphogenesis, Inc.
Via GlobeNewswire
News headline image
CWBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of CohBar, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy
From CohBar, Inc.
Via GlobeNewswire
News headline image
CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
Conference call and webcast today at 5:00 p.m. ET, November 8, 2022 
From CohBar, Inc.
Via GlobeNewswire
News headline image
CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022
Company to host conference call and webcast at 5:00 p.m. ET 
From CohBar, Inc.
Via GlobeNewswire
How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients
Via FinancialNewsMedia